Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-20-020243
Filing Date
2020-09-25
Accepted
2020-09-25 16:06:54
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dffn20200924_s3.htm S-3 417013
2 EXHIBIT 4.3 ex_204927.htm EX-4.3 334762
3 EXHIBIT 5.1 ex_205130.htm EX-5.1 29107
4 EXHIBIT 23.1 ex_204928.htm EX-23.1 3357
5 a1.jpg GRAPHIC 10029
6 dffn20200924_s3img001.jpg GRAPHIC 8812
  Complete submission text file 0001437749-20-020243.txt   806319
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249057 | Film No.: 201200212
SIC: 2834 Pharmaceutical Preparations